Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis
- 1 December 2019
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 72, 206-213
Abstract
Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (lncRNA, MALAT1) has been found to be aberrantly expressed in osteosarcoma, while high MALAT1 expression is correlated with both metastasis and prognosis. This meta-analysis set out to investigate the prognostic value of lncRNA MALAT1 in patients living with osteosarcoma. We conducted a systematical search of available databases from inception to May 2019. Odds ratios (OR) of clinical parameters, as well as hazard ratio (HR) of overall survival (OS), were calculated in order to evaluate the relationship between MALAT1 expression and the prognosis of patients living with osteosarcoma. Nine eligible studies which included a total of 599 osteosarcoma patients were enrolled in the present study. Pooled results found that high MALAT1 expression was associated with clinical stage and distant metastasis, but not age, gender, tumor anatomical location or tumor size. When compared to patients with low MALAT1 expression, patients with high MALAT1 expression were markedly correlated with a worse OS. Moreover, MALAT1 may be an independent predictive factor for OS in patients living with osteosarcoma. This meta-analysis suggests that high MALAT1 expression is associated with advanced clinicopathological features as well as unfavorable prognosis. LncRNA MALAT1 has the potential to serve as a moderate prognostic biomarker for osteosarcoma.Keywords
Funding Information
- National Natural Science Foundation of China (81772403, 81660317, 81772403, 81660317)
This publication has 23 references indexed in Scilit:
- FOXO1‐MALAT1‐miR-26a-5p Feedback Loop Mediates Proliferation and Migration in Osteosarcoma CellsOncology Research, 2017
- MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2Oncotarget, 2017
- Review of Osteosarcoma and Current ManagementRheumatology and Therapy, 2016
- Improvement in High-Grade Osteosarcoma SurvivalMedicine, 2016
- Unique features of long non-coding RNA biogenesis and functionNature Reviews Genetics, 2015
- Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcomaJournal of Orthopaedic Research, 2015
- MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathwayTumor Biology, 2014
- Structure and function of long noncoding RNAs in epigenetic regulationNature Structural & Molecular Biology, 2013
- International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly personsInternational Journal of Cancer, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007